Clinical Trial Update: Investigation of Pharmacokinetics,Safety,and Pharmacodynamics of HRS-5965 in Subjects With Hepatic Impairment [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetics, safety, and pharmacodynamics study of HRS-5965 in subjects with hepatic impairment, investigating its potential for complement-mediate…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glomerulopathy

Drugs mentioned

• HRS-5965

Snippet

Sponsor: Chengdu Suncadia Medicine Co., Ltd. | Conditions: Complement Mediated Primary or Secondary Glomerular Diseases | Phase 1 | Status: COMPLETED